FCE-27164

N/A

Report date: 2024/12/04 11:20:34
NME

Base Information

Drug NameFCE-27164
Drug Alias NameFCE-27164
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonistsHepatocyte growth factor receptor inhibitors
TargetsFibroblast growth factor receptorsHepatocyte growth factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFarmitalia Carlo Erba Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFarmitalia Carlo Erba Srl
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A